New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2013
08:19 EDTVARVarian Medical receives FDA clearance for Vitesse Brachytherapy treatment
Varian Medical has received an FDA 510k clearance for the latest version of its Vitesse real time planning for HDR brachytherapy which is used to plan and perform high-dose-rate (HDR), ultrasound-guided brachytherapy treatments for prostate cancer.
News For VAR From The Last 14 Days
Check below for free stories on VAR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2014
16:26 EDTVARVarian Medical sees Q3 EPS $1.06-$1.10, consensus $1.13
Subscribe for More Information
16:25 EDTVARVarian Medical backs 2014 EPS view $4.06-$4.18, consensus $4.30
Subscribe for More Information
16:24 EDTVARVarian Medical reports Q2 EPS 88c with charges, consensus $1.03
Subscribe for More Information
April 10, 2014
16:45 EDTVARVarian Medical settles patent dispute with University of Pittsburgh
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use